Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Advances in epigenetics in systemic sclerosis: molecular mechanisms and therapeutic potential
Pei‐Suen Tsou, John Varga, Steven O’Reilly
Nature Reviews Rheumatology (2021) Vol. 17, Iss. 10, pp. 596-607
Closed Access | Times Cited: 80

Showing 26-50 of 80 citing articles:

The Role of Non‐Coding RNA in Systemic Sclerosis: From Mechanism to Translation
Ruixuan Zhu, Zixin Pi, Yaqian Shi, et al.
Wiley Interdisciplinary Reviews - RNA (2025) Vol. 16, Iss. 2
Closed Access
Differential modulations of miRNAs in patients with systemic sclerosis-associated skeletal muscle loss
Federica Tambaro, Antonietta Gigante, Carmen Gallicchio, et al.
European Journal of Internal Medicine (2025)
Closed Access
Quantitative Digital Image Analysis for Assessing Cutaneous Fibrosis Correlates with Histopathological Scoring in Systemic Sclerosis Patients
Ruben Oganesyan, Dimitra Pouli, Bo Shi, et al.
Laboratory Investigation (2025), pp. 104177-104177
Closed Access
When natural antibodies become pathogenic: autoantibodies targeted against G protein-coupled receptors in the pathogenesis of systemic sclerosis
Reza Akbarzadeh, Antje Müller, Jens Y. Humrich, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 10
Matrix stiffness‐induced α‐tubulin acetylation is required for skin fibrosis formation through activation of Yes‐associated protein
Dongsheng Wen, Ya Gao, Yang Liu, et al.
MedComm (2023) Vol. 4, Iss. 4
Open Access | Times Cited: 10
The role of immunosuppressive myofibroblasts in the aging process and age-related diseases
Antero Salminen
Journal of Molecular Medicine (2023) Vol. 101, Iss. 10, pp. 1169-1189
Open Access | Times Cited: 10
Advances in biological and targeted therapies for systemic sclerosis
Erica Mulcaire-Jones, Andrea Hsiu Ling Low, Robyn T. Domsic, et al.
Expert Opinion on Biological Therapy (2023) Vol. 23, Iss. 4, pp. 325-339
Closed Access | Times Cited: 9
Absence of HDAC3 by Matrix Stiffness Promotes Chromatin Remodeling and Fibroblast Activation in Idiopathic Pulmonary Fibrosis
Fernanda Toscano-Marquez, Yair Romero, Marco Espina-Ordoñez, et al.
Cells (2023) Vol. 12, Iss. 7, pp. 1020-1020
Open Access | Times Cited: 8
Hypoxia-Inducible Factor-1α (HIF-1α) as a Biomarker for Changes in Microcirculation in Individuals with Systemic Sclerosis
Magdalena Maciejewska, Mariusz Sikora, Albert Stec, et al.
Dermatology and Therapy (2023) Vol. 13, Iss. 7, pp. 1549-1560
Open Access | Times Cited: 8
Influence of S100A2 in Human Diseases
Hitomi Sugino, Yu Sawada
Diagnostics (2022) Vol. 12, Iss. 7, pp. 1756-1756
Open Access | Times Cited: 12
Cannabidiol markedly alleviates skin and liver fibrosis
Carmen del Río, Francisco Ruíz-Pino, María E. Prados, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 12
MiR-27a as a diagnostic biomarker and potential therapeutic target in systemic sclerosis
Paria Bayati, Mahsa Kalantari, Mohammad‐Ali Assarehzadegan, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 12
Recent Insights into the Role of DNA Methylation and Histone Modifications in Systemic Sclerosis: A Scoping Review
Tsvetelina Kostova, Rositsa Karalilova, Z Batalov, et al.
Diagnostics (2024) Vol. 14, Iss. 6, pp. 652-652
Open Access | Times Cited: 2
Intracellular Pathogens: Infection, Immunity, and Intervention
Anna Martens-Koop, Aneesh Thakur
Methods in molecular biology (2024), pp. 1-17
Closed Access | Times Cited: 2
The involvement of HDAC3 in the pathogenesis of lung injury and pulmonary fibrosis
Hanming Yu, Shi Liu, Shuo Wang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Gut microbiota in very early systemic sclerosis: the first case-control taxonomic and functional characterisation highlighting an altered butyric acid profile
Silvia Bellando-Randone, Edda Russo, Leandro Di Gloria, et al.
RMD Open (2024) Vol. 10, Iss. 4, pp. e004647-e004647
Open Access | Times Cited: 2
Critical Analysis of Cytoplasmic Progression of Inflammatory Signaling Suggests Potential Pharmacologic Targets for Wound Healing and Fibrotic Disorders
Michael L. Samulevich, Liam E. Carman, Brian J. Aneskievich
Biomedicines (2024) Vol. 12, Iss. 12, pp. 2723-2723
Open Access | Times Cited: 2
Epigenetic Modifications in the Pathogenesis of Systemic Sclerosis
Jiangfan Yu, Rui Tang, Ke Ding
International Journal of General Medicine (2022) Vol. Volume 15, pp. 3155-3166
Open Access | Times Cited: 10
Reduced SPAG17 Expression in Systemic Sclerosis Triggers Myofibroblast Transition and Drives Fibrosis
Paulene Sapao, Elisha Roberson, Bo Shi, et al.
Journal of Investigative Dermatology (2022) Vol. 143, Iss. 2, pp. 284-293
Open Access | Times Cited: 10
Therapeutic effects of adipose-derived mesenchymal stem/stromal cells with enhanced migration ability and hepatocyte growth factor secretion by low-molecular-weight heparin treatment in bleomycin-induced mouse models of systemic sclerosis
Takayasu Suzuka, Takuya Kotani, Takashi Saito, et al.
Arthritis Research & Therapy (2022) Vol. 24, Iss. 1
Open Access | Times Cited: 10
Changes in peripheral T-lymphocyte subsets and serum cytokines in patients with systemic sclerosis
Ronghong Guo, Hao Cheng, Xiaoying Zhang, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 10
Aberrant expression of miR-138 as a novel diagnostic biomarker in systemic sclerosis
Paria Bayati, Hadi Poormoghim, Nazanin Mojtabavi
Biomarker Insights (2022) Vol. 17
Open Access | Times Cited: 10
The Microbiome in Systemic Sclerosis: Pathophysiology and Therapeutic Potential
Suhee Kim, Hee Jin Park, Sang‐Il Lee
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 24, pp. 16154-16154
Open Access | Times Cited: 10
Role of Interleukin-6 Family Cytokines in Organ Fibrosis
Ying Chen, Jiaxin Zhou, Shihui Xu, et al.
Kidney Diseases (2023) Vol. 9, Iss. 4, pp. 239-253
Open Access | Times Cited: 6
Bioinformatics-integrated screening of systemic sclerosis-specific expressed markers to identify therapeutic targets
Jiahui Jin, Yifan Liu, Qinyu Tang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 6

Scroll to top